ARTICLE | Politics, Policy & Law
BIO crafting short- and long-term responses to SVB failure
Webinar planned for this week with Cooley; BIO readying to advocate for biotechs as regulatory reforms take shape
March 14, 2023 8:36 PM UTC
Updated on Mar 15, 2023 at 5:38 PM UTC
About 50 biotech CEOs, bleary eyed after a tumultuous weekend, hopped on a call Monday organized by BIO’s Emerging Companies Section to exchange information and discuss the trade association’s role in supporting companies caught up in the Silicon Valley Bank meltdown.
They discussed plans some CEOs made over the weekend to cover payroll from their personal resources, and veteran industry leaders provided advice to colleagues who haven’t had to navigate this kind of storm, Rachel King, BIO’s interim president and CEO, told BioCentury Tuesday. ...